Literature DB >> 24378943

Trends in hospitalizations among children and young adults with perinatally acquired HIV.

Stephen A Berry1, Kelly A Gebo, Richard M Rutstein, Keri N Althoff, P Todd Korthuis, Aditya H Gaur, Stephen A Spector, Robert Warford, Baligh R Yehia, Allison L Agwu.   

Abstract

BACKGROUND: Contemporary trends in hospitalization patterns among perinatally HIV-infected (PHIV) patients are unknown. We describe rates and reasons for hospitalizations stratified by age group during 2003-2010 within a large cohort of PHIV patients.
METHODS: 579 PHIV patients engaged in care at 6 geographically diverse pediatric HIV centers affiliated through the HIV Research Network were included. Modified Clinical Classification Software assigned primary ICD-9 codes into diagnostic categories. Analysis was performed using negative binomial regression with generalized estimating equations.
RESULTS: There were 699 all-cause hospitalizations. The overall rate for the full cohort was 19.9/100 person-years, and overall rates for 0-4, 5-16 and 17-24 year-olds were 25.1, 14.7 and 34.2/100 person-years, respectively. Declines were seen in unadjusted all-cause rates for the whole group [incidence rate ratio per year, 0.93 (0.87-0.99)] and for 5-16 [0.87 (0.76-0.99)] and 17-24 year-olds [0.87 (0.80-0.95)]. After adjustment for CD4, HIV-1 RNA and demographics, rates were no longer declining. Non-AIDS-defining infections and AIDS-defining illnesses together caused 349 (50%) admissions. Declines in these categories drove the overall declines in unadjusted rates. No increases over time were seen for cardiovascular, renal or any other diagnostic categories.
CONCLUSIONS: While the declines in hospitalizations are reassuring, continued efforts are needed to address the persistently high infectious and non-infectious morbidity among PHIV patients. Innovative strategies may be most critical for 17-24 year-olds. Lack of increases in cardiovascular and renal admissions provides modest, preliminary reassurance against severe non-infectious complications from longstanding HIV infection and antiretroviral exposure.

Entities:  

Mesh:

Year:  2014        PMID: 24378943      PMCID: PMC4215549          DOI: 10.1097/INF.0000000000000126

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  33 in total

1.  Long-term outcomes in adolescents perinatally infected with HIV-1 and followed up since birth in the French perinatal cohort (EPF/ANRS CO10).

Authors:  C Dollfus; J Le Chenadec; A Faye; S Blanche; N Briand; C Rouzioux; J Warszawski
Journal:  Clin Infect Dis       Date:  2010-07-15       Impact factor: 9.079

2.  Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

Authors:  R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

3.  Clinical outcomes improve with highly active antiretroviral therapy in vertically HIV type-1-infected children.

Authors:  Salvador Resino; Rosa Resino; José Maria Bellón; Dariela Micheloud; Maria Dolores Gurbindo Gutiérrez; Maria Isabel de José; José Tomás Ramos; Pablo Martín Fontelos; Luis Ciria; Maria Angeles Muñoz-Fernández
Journal:  Clin Infect Dis       Date:  2006-06-09       Impact factor: 9.079

4.  Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.

Authors:  Thanyawee Puthanakit; Linda Aurpibul; Peninnah Oberdorfer; Noppadon Akarathum; Suparat Kanjananit; Pornphun Wannarit; Thira Sirisanthana; Virat Sirisanthana
Journal:  Clin Infect Dis       Date:  2007-01-09       Impact factor: 9.079

5.  Abnormal cardiac strain in children and young adults with HIV acquired in early life.

Authors:  Amy Sims; Lowell Frank; Russell Cross; Sarah Clauss; David Dimock; Julia Purdy; Irene Mikhail; Rohan Hazra; Colleen Hadigan; Craig Sable
Journal:  J Am Soc Echocardiogr       Date:  2012-04-26       Impact factor: 5.251

6.  Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.

Authors:  Ali Judd; Katherine L Boyd; Wolfgang Stöhr; David Dunn; Karina Butler; Hermione Lyall; Mike Sharland; Delane Shingadia; Andrew Riordan; Di M Gibb
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

7.  Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.

Authors:  José Manuel Sánchez; José Tomás Ramos Amador; Sira Fernández de Miguel; María Isabel González Tomée; Pablo Rojo Conejo; Paloma Ferrnado Vivas; Julián Clemente Vivas; Jesús Ruiz Contreras; Angel Nogales Espert
Journal:  Pediatr Infect Dis J       Date:  2003-10       Impact factor: 2.129

8.  Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.

Authors:  Kate Buchacz; Rose K Baker; Anne C Moorman; James T Richardson; Kathleen C Wood; Scott D Holmberg; John T Brooks
Journal:  AIDS       Date:  2008-07-11       Impact factor: 4.177

9.  Young people in the United Kingdom and Ireland with perinatally acquired HIV: the pediatric legacy for adult services.

Authors:  Caroline Foster; Ali Judd; Pat Tookey; Gareth Tudor-Williams; David Dunn; Delane Shingadia; Karina Butler; Mike Sharland; Di Gibb; Hermione Lyall
Journal:  AIDS Patient Care STDS       Date:  2009-03       Impact factor: 5.078

10.  Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care.

Authors:  Ali Judd; Katja Doerholt; Pat A Tookey; Mike Sharland; Andrew Riordan; Esse Menson; Vas Novelli; E G Hermione Lyall; Janet Masters; Gareth Tudor-Williams; Trinh Duong; Di M Gibb
Journal:  Clin Infect Dis       Date:  2007-08-27       Impact factor: 9.079

View more
  6 in total

1.  Association of Risk of Viremia, Immunosuppression, Serious Clinical Events, and Mortality With Increasing Age in Perinatally Human Immunodeficiency Virus-Infected Youth.

Authors:  Anne M Neilan; Brad Karalius; Kunjal Patel; Russell B Van Dyke; Mark J Abzug; Allison L Agwu; Paige L Williams; Murli Purswani; Deborah Kacanek; James M Oleske; Sandra K Burchett; Andrew Wiznia; Miriam Chernoff; George R Seage; Andrea L Ciaranello
Journal:  JAMA Pediatr       Date:  2017-05-01       Impact factor: 16.193

2.  Trends in Diagnoses Among Hospitalizations of HIV-infected Children and Adolescents in the United States: 2003-2012.

Authors:  Stacey A Hurst; Alexander C Ewing; Sascha R Ellington; Athena P Kourtis
Journal:  Pediatr Infect Dis J       Date:  2017-10       Impact factor: 2.129

3.  Disease- and Treatment-related Morbidity in Adolescents With Perinatal HIV Infection in Asia.

Authors:  Adam W Bartlett; Thahira Jamal Mohamed; Tavitiya Sudjaritruk; Nia Kurniati; Revathy Nallusamy; Rawiwan Hansudewechakul; Penh Sun Ly; Khanh Huu Truong; Pagakrong Lumbiganon; Thanyawee Puthanakit; Kulkanya Chokephaibulkit; Lam Van Nguyen; Viet Chau Do; Nagalingeswaran Kumarasamy; Nik Khairulddin Nik Yusoff; Moy Siew Fong; Dewi Kumara Wati; Annette H Sohn; Azar Kariminia
Journal:  Pediatr Infect Dis J       Date:  2019-03       Impact factor: 2.129

4.  Predictors of Hospitalization among Children on ART in Ethiopia: a Cohort study.

Authors:  Abraham Haileamlak; Tesfalem Hagos; Workeabeba Abebe; Loko Abraham; Henok Asefa; Alula M Teklu
Journal:  Ethiop J Health Sci       Date:  2017-02

5.  Recruitment of Youth Living With HIV to Optimize Adherence and Virologic Suppression: Testing the Design of Technology-Based Community Health Nursing to Improve Antiretroviral Therapy (ART) Clinical Trials.

Authors:  Allison Lorna Agwu; Hasiya Eihuri Yusuf; Lawrence D'Angelo; Mobeen Rathore; Jeanette Marchesi; Julia Rowell; Raina Smith; Jackie Toppins; Constance Trexler; Rashida Carr; Betty Johnson; Aaron Keith Selden; Saniyyah Mahmoudi; Susan Black; Jisell Guadamuz; Steven Huettner; Maria Trent
Journal:  JMIR Res Protoc       Date:  2020-12-11

6.  Higher Acuity Resource Utilization With Older Age and Poorer HIV Control in Adolescents and Young Adults in the HIV Research Network.

Authors:  Anne M Neilan; Frances Lu; Kelly A Gebo; Rebeca Diaz-Reyes; Mingshu Huang; Robert A Parker; Brad Karalius; Kunjal Patel; Cindy Voss; Andrea L Ciaranello; Allison L Agwu
Journal:  J Acquir Immune Defic Syndr       Date:  2020-04-01       Impact factor: 3.771

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.